Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

herbalife ltd. - HLF

HLF

Close Chg Chg %
8.50 -0.08 -0.88%

Closed Market

8.42

-0.08 (0.88%)

Volume: 1.83M

Last Updated:

Nov 22, 2024, 3:59 PM EDT

Trade Now

Company Overview: herbalife ltd. - HLF

HLF Key Data

Open

$8.51

 Day Range

8.42 - 8.70

52 Week Range

6.59 - 15.66

 Market Cap

$856.73M

Shares Outstanding

100.79M

 Public Float

97.65M

Beta

1.18

 Rev. Per Employee

N/A

P/E Ratio

9.95

 EPS

$0.86

Yield

0.00%

 Dividend

$0.30

EX-DIVIDEND DATE

Feb 28, 2014

 SHORT INTEREST

N/A

AVERAGE VOLUME

2.71M

  

HLF Performance

1 Week
 
 6.18%
 
1 Month
 
 25.11%
 
3 Months
 
 -2.66%
 
1 Year
 
 -34.37%
 
5 Years
 
 -81.23%
 

HLF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About herbalife ltd. - HLF

Herbalife Ltd. is a holding company, which engages in the provision of health and wellness products. It operates through the following geographical segments: North America, Latin America, EMEA, Asia Pacific, and China. The company was founded by Mark Reynolds Hughes in February 1980 and is headquartered in Los Angeles, CA.

HLF At a Glance

Herbalife Ltd.
800 West Olympic Boulevard
Los Angeles, California 90015
Phone N/A Revenue 5.06B
Industry Medical Distributors Net Income 142.20M
Sector Distribution Services Employees 9,200
Fiscal Year-end 12 / 2024
View SEC Filings

HLF Valuation

P/E Current 9.953
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 10.753
Price to Sales Ratio 0.302
Price to Book Ratio N/A
Price to Cash Flow Ratio 4.277
Enterprise Value to EBITDA 8.556
Enterprise Value to Sales 0.732
Total Debt to Enterprise Value 0.747

HLF Efficiency

Revenue/Employee 550,260.87
Income Per Employee 15,456.522
Receivables Turnover 51.657
Total Asset Turnover 1.827

HLF Liquidity

Current Ratio 1.095
Quick Ratio 0.70
Cash Ratio 0.462

HLF Profitability

Gross Margin 74.68
Operating Margin 6.323
Pretax Margin 4.01
Net Margin 2.809
Return on Assets 5.132
Return on Equity N/A
Return on Total Capital 8.32
Return on Invested Capital 9.643

HLF Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 162.035
Total Debt to Total Assets 98.58
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 141.616
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Herbalife Ltd. - HLF

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
5.54B 5.80B 5.20B 5.06B
Sales Growth
+13.63% +4.71% -10.31% -2.73%
Cost of Goods Sold (COGS) incl D&A
1.23B 1.32B 1.26B 1.28B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
100.30M 107.60M 115.40M 113.30M
Depreciation
80.90M 89.20M 94.30M 88.90M
Amortization of Intangibles
19.40M 18.40M 21.10M 24.40M
COGS Growth
+19.36% +7.31% -5.06% +2.02%
Gross Income
4.31B 4.48B 3.95B 3.78B
Gross Income Growth
+12.09% +3.97% -11.86% -4.24%
Gross Profit Margin
+77.75% +77.19% +75.86% +74.68%
2020 2021 2022 2023 5-year trend
SG&A Expense
3.56B 3.75B 3.41B 3.46B
Research & Development
- - - -
-
Other SG&A
3.56B 3.75B 3.41B 3.46B
SGA Growth
+7.60% +5.19% -8.98% +1.42%
Other Operating Expense
- - - -
-
Unusual Expense
123.70M 36.00M (500.00K) (1.60M)
EBIT after Unusual Expense
621.20M 694.80M 536.60M 321.70M
Non Operating Income/Expense
27.70M 18.20M 27.70M 47.20M
Non-Operating Interest Income
8.80M 4.40M 6.10M 11.50M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
132.50M 152.20M 139.50M 166.20M
Interest Expense Growth
-13.40% +14.87% -8.34% +19.14%
Gross Interest Expense
132.50M 152.20M 139.50M 166.20M
Interest Capitalized
- - - -
-
Pretax Income
516.40M 560.80M 424.80M 203.00M
Pretax Income Growth
+14.40% +8.60% -24.25% -52.21%
Pretax Margin
+9.32% +9.66% +8.16% +4.01%
Income Tax
143.80M 113.60M 103.50M 60.80M
Income Tax - Current - Domestic
19.80M 25.10M 33.30M 21.10M
Income Tax - Current - Foreign
122.00M 121.80M 100.10M 80.80M
Income Tax - Deferred - Domestic
4.70M (16.30M) (27.90M) (39.40M)
Income Tax - Deferred - Foreign
(2.70M) (17.00M) (2.00M) (1.70M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
372.60M 447.20M 321.30M 142.20M
Minority Interest Expense
- - - -
-
Net Income
372.60M 447.20M 321.30M 142.20M
Net Income Growth
+19.81% +20.02% -28.15% -55.74%
Net Margin Growth
+6.72% +7.71% +6.17% +2.81%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
372.60M 447.20M 321.30M 142.20M
Preferred Dividends
- - - -
-
Net Income Available to Common
372.60M 447.20M 321.30M 142.20M
EPS (Basic)
2.8335 4.2228 3.2619 1.4364
EPS (Basic) Growth
+25.18% +49.03% -22.76% -55.96%
Basic Shares Outstanding
131.50M 105.90M 98.50M 99.00M
EPS (Diluted)
2.7703 4.1293 3.2292 1.4192
EPS (Diluted) Growth
+26.13% +49.06% -21.80% -56.05%
Diluted Shares Outstanding
134.50M 108.30M 99.50M 100.20M
EBITDA
845.20M 838.40M 651.50M 433.40M
EBITDA Growth
+34.24% -0.80% -22.29% -33.48%
EBITDA Margin
+15.25% +14.45% +12.52% +8.56%

Snapshot

Average Recommendation HOLD Average Target Price 11.80
Number of Ratings 7 Current Quarters Estimate 0.132
FY Report Date 12 / 2024 Current Year's Estimate 1.733
Last Quarter’s Earnings 0.57 Median PE on CY Estimate N/A
Year Ago Earnings 2.21 Next Fiscal Year Estimate 2.023
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 4 5 5
Mean Estimate 0.13 0.43 1.73 2.02
High Estimates 0.25 0.48 1.85 2.19
Low Estimate -0.10 0.37 1.51 1.83
Coefficient of Variance 107.64 13.74 7.92 7.28

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 4 4 4
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Herbalife Ltd. - HLF

Date Name Shares Transaction Value
May 13, 2024 Juan Miguel Mendoza Director 80,779 Open market or private purchase of non-derivative security Non-derivative transaction at $10.17 per share 821,522.43
May 13, 2024 Juan Miguel Mendoza Director 86,279 Open market or private purchase of non-derivative security Non-derivative transaction at $10.59 per share 913,694.61
May 13, 2024 Juan Miguel Mendoza Director 93,279 Open market or private purchase of non-derivative security Non-derivative transaction at $10.65 per share 993,421.35
May 8, 2024 Alan W. LeFevre Director 69,117 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Jehangir D. Irani SVP, PAO 66,573 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $9.58 per share 637,769.34
May 8, 2024 Sophie L'Hélias Director 43,746 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Frank Lamberti Chief Operating Officer 212,550 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Frank Lamberti Chief Operating Officer 248,838 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $9.58 per share 2,383,868.04
May 8, 2024 Frank Lamberti Chief Operating Officer 250,857 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Ibelis Inglewood Fleming EVP & Chief of Staff 151,821 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Ibelis Inglewood Fleming EVP & Chief of Staff 160,812 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $9.58 per share 1,540,578.96
May 8, 2024 Ibelis Inglewood Fleming EVP & Chief of Staff 162,831 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Michael Jeffrey Levitt Director 15,657 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Rodica Macadrai Director 33,705 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Celine Del Genes Director 33,961 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Richard H. Carmona Director 49,909 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 María Otero Director 58,193 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Henry C. Wang EVP, General Counsel 212,550 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Henry C. Wang EVP, General Counsel 213,673 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Henry C. Wang EVP, General Counsel 209,325 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $9.58 per share 2,005,333.50

Herbalife Ltd. in the News